Euclidean Capital LLC - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 77 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.

Quarter-by-quarter ownership
Euclidean Capital LLC ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$6,995,129
-48.6%
989,4100.0%0.88%
-49.6%
Q1 2024$13,604,388
+49.5%
989,4100.0%1.74%
+70.3%
Q4 2023$9,102,572
-24.0%
989,410
-50.0%
1.02%
-21.6%
Q3 2023$11,971,862
+106.4%
1,978,820
+164.7%
1.31%
-12.4%
Q2 2023$5,800,988
+36.1%
747,5500.0%1.49%
-60.1%
Q1 2023$4,261,035
-3.2%
747,5500.0%3.74%
-9.2%
Q4 2022$4,403,070
+84.1%
747,5500.0%4.12%
+85.5%
Q3 2022$2,392,000
-28.6%
747,5500.0%2.22%
-22.0%
Q2 2022$3,349,000
-16.1%
747,5500.0%2.85%
+22.8%
Q1 2022$3,992,000
-63.7%
747,5500.0%2.32%
-62.9%
Q4 2021$10,989,000
-32.4%
747,550
-3.8%
6.25%
-20.9%
Q3 2021$16,251,000
-7.8%
777,193
-22.0%
7.90%
+38.0%
Q2 2021$17,632,000
-27.8%
996,7340.0%5.72%
-30.0%
Q1 2021$24,420,000
-48.5%
996,734
-28.8%
8.17%
-18.6%
Q4 2020$47,405,0001,400,43510.04%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 496,893$16,760,00014.90%
Svennilson Peter 4,768,181$160,831,00013.45%
Invus Financial Advisors, LLC 1,007,576$33,986,00012.28%
EcoR1 Capital, LLC 2,642,218$89,122,0006.58%
Foresite Capital Management IV, LLC 125,000$4,216,0002.05%
Orbimed Advisors 2,921,967$98,558,0001.39%
Casdin Capital, LLC 251,515$8,484,0000.50%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 191,568$6,462,0000.50%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 300,000$10,119,0000.30%
EMERALD ADVISERS, LLC 186,140$6,279,0000.27%
View complete list of ORIC PHARMACEUTICALS INC shareholders